Jbs N.V. (NYSE:JBS) Receives Average Rating of “Moderate Buy” from Analysts

Jbs N.V. (NYSE:JBS) has received a consensus rating of “Moderate Buy” from the eight research firms that are currently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, one has given a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is $18.4167.

A number of equities research analysts have commented on JBS shares. UBS Group raised their price target on JBS from $17.00 to $17.50 and gave the company a “buy” rating in a report on Monday, August 24th. Stephens dropped their price objective on JBS from $18.00 to $17.00 and set an “overweight” rating for the company in a research note on Monday, August 17th. Wall Street Zen cut JBS from a “hold” rating to a “sell” rating in a report on Saturday, August 15th. Weiss Ratings downgraded JBS from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Thursday, September 3rd. Finally, Zacks Research upgraded shares of JBS from a “strong sell” rating to a “hold” rating in a research report on Monday, July 13th.

Insider Transactions at JBS

In other JBS news, CFO Guilherme Cavalcanti sold 183,501 shares of the business’s stock in a transaction on Monday, August 24th. The shares were sold at an average price of $13.85, for a total value of $2,541,488.85. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Institutional Investors Weigh In On JBS

Several large investors have recently made changes to their positions in the company. Rhumbline Advisers bought a new position in JBS during the second quarter valued at approximately $203,000. Arrowstreet Capital Limited Partnership purchased a new stake in JBS during the second quarter valued at $5,490,000. EverSource Wealth Advisors LLC purchased a new stake in JBS during the second quarter valued at $29,000. First Trust Advisors LP bought a new position in JBS during the second quarter valued at $1,419,000. Finally, Marshall Wace LLP bought a new position in JBS during the second quarter valued at $5,206,000.

JBS Stock Performance

Shares of NYSE JBS opened at $12.57 on Friday. The firm has a fifty day moving average price of $13.06 and a 200-day moving average price of $14.24. The company has a debt-to-equity ratio of 2.51, a current ratio of 1.53 and a quick ratio of 0.77. The stock has a market cap of $9.76 billion, a PE ratio of 12.33, a price-to-earnings-growth ratio of 4.70 and a beta of -1.67. JBS has a 1 year low of $11.49 and a 1 year high of $18.65.

JBS (NYSE:JBS) last announced its quarterly earnings data on Monday, August 10th. The company reported $0.20 EPS for the quarter, missing the consensus estimate of $0.32 by ($0.12). JBS had a net margin of 1.22% and a return on equity of 12.00%. The firm had revenue of $23.90 billion for the quarter. The business’s quarterly revenue was up 13.8% compared to the same quarter last year. Equities analysts anticipate that JBS will post 1.08 earnings per share for the current fiscal year.

JBS Company Profile

JBS SA is a Brazil-based global food company that produces and sells animal-protein and prepared-food products. Its portfolio includes beef, pork, poultry, lamb, plant-based foods and value-added prepared meals, along with leather and other products derived from its processing operations.

Founded in 1953 by José Batista Sobrinho in Anápolis, Brazil, JBS has expanded from a local cattle-processing business into one of the world’s largest protein companies. Its operations and products serve customers in Brazil and international markets across North America, South America, Europe, Asia, Africa and Australia.

JBS markets products under brands that include Friboi, Seara, Swift, Pilgrim’s, Primo and 1855, although brand availability varies by country and product category.